Now I have a thorough understanding of the paper and can verify each reviewer claim. Let me produce the consolidated review.

## Summary

The paper introduces SUFO, a systematic interpretability framework combining Supervised probing, Unsupervised similarity (RSA), Feature dynamics (cluster analysis), and Outlier analysis to analyze fine-tuned transformer feature spaces. Through a case study on clinical text classification (pathology reports + MedNLI) with five 110M-parameter models spanning general-domain (BERT, TNLR), mixed-domain (BioBERT, Clinical BioBERT), and domain-specific (PubMedBERT) pre-training, the paper reports three main findings: (1) domain-specific PubMedBERT overfits to minority classes under imbalance despite having informative pre-trained features, (2) in-domain pre-training accelerates feature disambiguation, and (3) fine-tuned feature spaces sparsify, enabling outlier analysis validated by a clinician.

## Strengths

- **Counterintuitive finding about domain-specific pre-training under class imbalance**: The paper shows PubMedBERT (domain-specific), despite having the highest probing F1 (0.494), performs poorly on the imbalanced Path-PG task (F1=0.770, std=0.12) compared to mixed-domain Clinical BioBERT (0.959, std=0.03). This pattern is partially corroborated by MedNLI simulations (Section 4.2). This finding is interesting and practically relevant for practitioners choosing pre-trained models.

- **Feature dynamics analysis reveals meaningful cross-model patterns**: The PCA-based cluster analysis across layers and training time (Section 5.2) provides concrete evidence that in-domain models (BioBERT, Clinical BioBERT, PubMedBERT) disambiguate classes faster (~epoch 6) than general-domain models (~epoch 9). The observation that PubMedBERT's feature mixing on Path-PG corroborates its degraded fine-tuning performance adds convergent validity.

- **Domain expert evaluation grounds outlier analysis in clinical practice**: The identification of five common outlier modes (wrong labels, inconsistent reports, multiple sources, truncated reports, boundary cases) with clinician feedback (Section 6.2) demonstrates that the framework can yield clinically meaningful distinctions — e.g., Clinical BioBERT and PubMedBERT detecting more missing-medical-information cases than general-domain models.

## Weaknesses

### Fatal

None.

### Major

- **The central overfitting claim confounds "from-scratch" with "domain-specific" pre-training.** The paper attributes PubMedBERT's poor Path-PG performance (F1=0.770) to its "domain-specific" nature, contrasting with "mixed-domain" models. However, BioBERT — which is also pre-trained only on PubMed abstracts (domain-specific in terms of data source) but as *continual pre-training from BERT* — achieves F1=0.933 on Path-PG, much closer to Clinical BioBERT's 0.959 than to PubMedBERT's 0.770. This suggests the key factor may be *from-scratch vs. continual pre-training* rather than domain specificity vs. mixed-domain diversity. The paper's framing collapses these two factors. This is not a fatal flaw — the finding is still worth reporting — but the causal attribution needs to be significantly softened, and alternative explanations (vocabulary mismatch, smaller pre-training data scale in PubMedBERT, instability from scratch) should be discussed.

- **No significance testing or per-class metrics for the minority class.** Results in Table 1 are reported as F1 macro with standard deviations over 3 runs. Given the high variance on Path-PG (PubMedBERT std=0.12, BERT std=0.16, TNLR std=0.18), many pairwise comparisons could fall within noise. The paper's central narrative about minority-class overfitting would be substantially strengthened by reporting precision/recall for the Gleason 5 class specifically, along with bootstrapped confidence intervals or a statistical test.

### Minor

- **RSA interpretation is overclaimed.** The RSA analysis (Section 5.1) compares pre-trained vs. fine-tuned versions of the *same* model to measure within-model change. The paper then claims this "indicates the versatility of BERT's feature space for its ability to match models pre-trained using in-domain data with relatively little reconfiguration." This conclusion does not follow from the experiment — cross-model RSA would be needed to establish feature matching. The RSA findings about which layers change most during fine-tuning are valid and useful; only this one interpretive sentence overreaches.

- **Supervised probing advantage is negligible.** The paper states PubMedBERT's pre-trained features "contain the most useful information" based on probing F1=0.494 vs. BERT's 0.493 and Clinical BioBERT's 0.487. The margin over BERT is 0.001 — well within the reported standard deviations. This claim should be caveated as negligible in practical terms.

- **The outlier extraction method is heuristic and not validated against task performance.** Clustering via axis-aligned intervals on PC1/PC2 projections is ad-hoc, with no cross-validation or stability analysis. The clusters are derived from the training set only, and the paper acknowledges this limits test-set generalization. While the expert evaluation shows the outliers are interesting, it does not establish that the clustering captures *model-specific* failure modes versus label-conditional structure in the data.

- **No analysis of what the low-variance PCs encode.** The PC probing experiment shows a surge when adding back PC1 and PC2 (the high-variance components), but the paper does not analyze the content of the remaining PCs or explain the apparent fact that some low-variance directions might still encode discriminative signal. The relationship between variance explained and task relevance is left as an open question.

### Trivial

- The claim of being "the first to conduct such extensive cluster analysis on text features" (Section 5) is overstated — cluster analysis of BERT features for task-specific probing has been done in prior work (e.g., BERT QA probing papers cited by the authors themselves). This is a minor overclaim.

## Nice-to-Haves

- A controlled experiment isolating the "from-scratch vs. continual pre-training" confound: e.g., training a PubMedBERT-initialized model with BERT's vocabulary, or applying stronger regularization to PubMedBERT during fine-tuning.
- Per-class precision/recall and bootstrapped confidence intervals for the minority class on Path-PG.
- Cross-model RSA (fine-tuned BERT vs. fine-tuned PubMedBERT) to directly test whether feature spaces converge across models from different pre-training regimes.

## Removed Points

These points are flagged to be removed, treat them with caution:

1. **Critic's Issue 1 (contradiction in outlier analysis)**: The critic claimed the paper's PC probing shows "the smallest PCs are crucial" while the sparsification claim focuses on top PCs, creating a contradiction. This is a **misreading**. The paper explicitly says "the first 2 PCs contribute significantly" — these are PC1 and PC2, the same high-variance components that explain 95% of the variance. The critic confused "bottom k PCs" terminology with the paper's clear statement about "first 2 PCs." There is no contradiction; the paper's outlier analysis is built on a subspace that its own evidence confirms is task-relevant. *Removed as factually wrong.*

2. **Complaint about reproducibility (missing artifacts, implementation details)**: The critic's section-by-section notes include concerns about the private dataset and missing table content (parser artifacts). These are either parser artifacts (tables were stripped) or acknowledged limitations of a clinical dataset with protected health information. *Removed per hard rules.*

3. **Demand for additional breadth (more tasks, more datasets)**: Various scattered demands for broader evaluation that would turn the paper into a different, larger study. *Removed as scope creep.*

## Novel Insights

The most insightful observation from the reviews is the identification of the confound between "from-scratch" and "domain-specific" pre-training. BioBERT's strong performance on Path-PG (0.933) despite being trained only on PubMed abstracts (like PubMedBERT) suggests the paper's central attribution — that "mixed-domain pre-training confers robustness to class imbalance" — may be better framed as "continual pre-training from a general-domain initialization confers robustness." This reframing is more precise and would lead to different practical recommendations (prefer continual pre-training over from-scratch training for clinical tasks with expected imbalance). Beyond this, the reviews do not surface additional novel insights beyond what the paper itself contributes.

## Suggestions

1. **Reframe the overfitting claim.** Acknowledge that the observed pattern may be driven by from-scratch vs. continual pre-training, not domain-specific vs. mixed-domain per se. Report per-class metrics (precision/recall for Gleason 5) and add bootstrapped confidence intervals.
2. **Fix the RSA sentence.** Remove or rephrase the unsupported claim about BERT's "versatility" and "matching." The within-model RSA findings about which layers change most are valuable on their own.
3. **Add an ablation.** Training PubMedBERT with stronger regularization or with BERT's vocabulary would help disentangle the confound and deepen the paper's contribution.
4. **Soften the supervised probing claim.** The F1 difference of 0.001 between PubMedBERT and BERT is negligible and should be discussed as such.

## Score and Decision

The SUFO framework is well-motivated and yields valuable methodological scaffolding for interpretability. The feature dynamics analysis (Section 5.2) and the expert-validated outlier analysis (Section 6) are solid contributions. However, the paper's headline finding — that domain-specific models overfit under class imbalance while mixed-domain models are robust — has a significant confound that the paper does not address. BioBERT (same data source as PubMedBERT but continual pre-training from BERT) performs comparably to Clinical BioBERT, suggesting the key variable may be initialization rather than corpus diversity. Combined with high variance on the critical comparison and the absence of per-class metrics, this weakness undermines the paper's most prominent claim. The remaining contributions (framework, feature dynamics, outlier analysis) are worthwhile but not strong enough to compensate for an unsupported central finding in a conference venue. With revisions addressing the confound through additional experiments (e.g., regularized PubMedBERT, per-class metrics, confidence intervals), the paper could make a solid contribution.

MY FINAL SCORE: <pineapple>5.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>